FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers
December 28, 2017 -- Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
“Diabetes is the leading cause of lower limb amputations,”...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Dermatology | Diabetes | Diabetic Ulcers | Endocrinology | Food and Drug Administration (FDA) | Marketing | Pharmaceuticals